J. W. Vardiman
- Genetics top 0.5%
- Pathology and Forensic Medicine top 1%
- Hematology top 0.5%
- Molecular Biology top 10%
- Oncology top 5%
- Co-authors
- Ayalew TefferiGeorges FlandrinHans Konrad Müller‐HermelinkElaine S. JaffeJ DiéboldNancy L. HarrisT. ListerC. D. Bloomfield
- Topics
- Chronic Lymphocytic Leukemia Research (13 papers)Acute Myeloid Leukemia Research (12 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
J. W. Vardiman
37 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Genetics 1.7k
- Pathology and Forensic Medicine 1.2k
- Hematology 1.2k
- Molecular Biology 805
- Oncology 778
Countries citing papers authored by J. W. Vardiman
This map shows the geographic impact of J. W. Vardiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. W. Vardiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. W. Vardiman more than expected).
Fields of papers citing papers by J. W. Vardiman
This network shows the impact of papers produced by J. W. Vardiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. W. Vardiman. The network helps show where J. W. Vardiman may publish in the future.
Co-authorship network of co-authors of J. W. Vardiman
This figure shows the co-authorship network connecting the top 25 collaborators of J. W. Vardiman. A scholar is included among the top collaborators of J. W. Vardiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. W. Vardiman. J. W. Vardiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 33 | |
| 3 | Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithmsbreakdown → | 669 |
| 4 | 30 | |
| 5 | 12 | |
| 6 | 41 | |
| 7 | 2 | |
| 8 | THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES REPORT OF THE CLINICAL ADVISORY COMMITTEE MEETING | 167 |
| 9 | 240 | |
| 10 | 261 | |
| 11 | The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissuesbreakdown → | 649 |
| 12 | 11 | |
| 13 | Hematopathologic findings in the myeloproliferative disorders. | 46 |
| 14 | 42 | |
| 15 | 10 | |
| 16 | 60 | |
| 17 | 48 | |
| 18 | Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features. | 14 |
| 19 | 8 | |
| 20 | Prognostic significance of immunological tests in lung cancer. | 7 |
About J. W. Vardiman
J. W. Vardiman is a scholar working on Genetics, Hematology and Anatomy, having authored 37 papers that have together received 3.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (13 papers), Acute Myeloid Leukemia Research (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). The work is most often cited by research in Genetics (1.7k citations), Hematology (1.2k citations) and Pathology and Forensic Medicine (1.2k citations). J. W. Vardiman has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Ayalew Tefferi, Georges Flandrin, Hans Konrad Müller‐Hermelink, Elaine S. Jaffe, J Diébold, Nancy L. Harris, T. Lister, C. D. Bloomfield, HM Golomb and John Anastasi. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.